Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Buch |
| Sprache: | Englisch |
| Veröffentlicht: |
Basel [u.a.]
Karger
1998
|
| Schriftenreihe: | Onkologie
21, Suppl. 3 |
| Umfang: | VI, 70 S. graph. Darst. |
| ISBN: | 3805567421 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012118775 | ||
| 003 | DE-604 | ||
| 005 | 20150612 | ||
| 007 | t| | ||
| 008 | 980824s1998 xx d||| |||| 00||| eng d | ||
| 020 | |a 3805567421 |9 3-8055-6742-1 | ||
| 035 | |a (OCoLC)489155659 | ||
| 035 | |a (DE-599)BVBBV012118775 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 | ||
| 110 | 2 | |a Deutsche Krebsgesellschaft |b Arbeitsgemeinschaft für Internistische Onkologie |b Phase-Eins-Studiengruppe |e Verfasser |0 (DE-588)5290200-6 |4 aut | |
| 245 | 1 | 0 | |a Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society |c E.-D. Kreuser ... |
| 264 | 1 | |a Basel [u.a.] |b Karger |c 1998 | |
| 300 | |a VI, 70 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Onkologie |v 21, Suppl. 3 | |
| 700 | 1 | |a Kreuser, Ernst-Dietrich |d 1945- |e Sonstige |0 (DE-588)17219699X |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-008206770 | |
Datensatz im Suchindex
| _version_ | 1818954595489021952 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)17219699X |
| author_corporate | Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie Phase-Eins-Studiengruppe |
| author_corporate_role | aut |
| author_facet | Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie Phase-Eins-Studiengruppe |
| author_sort | Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie Phase-Eins-Studiengruppe |
| building | Verbundindex |
| bvnumber | BV012118775 |
| ctrlnum | (OCoLC)489155659 (DE-599)BVBBV012118775 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01171nam a2200277 cb4500</leader><controlfield tag="001">BV012118775</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150612 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">980824s1998 xx d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805567421</subfield><subfield code="9">3-8055-6742-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)489155659</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012118775</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Deutsche Krebsgesellschaft</subfield><subfield code="b">Arbeitsgemeinschaft für Internistische Onkologie</subfield><subfield code="b">Phase-Eins-Studiengruppe</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)5290200-6</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society</subfield><subfield code="c">E.-D. Kreuser ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 70 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Onkologie</subfield><subfield code="v">21, Suppl. 3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kreuser, Ernst-Dietrich</subfield><subfield code="d">1945-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)17219699X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008206770</subfield></datafield></record></collection> |
| id | DE-604.BV012118775 |
| illustrated | Illustrated |
| indexdate | 2024-12-20T10:24:40Z |
| institution | BVB |
| institution_GND | (DE-588)5290200-6 |
| isbn | 3805567421 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008206770 |
| oclc_num | 489155659 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-12 |
| physical | VI, 70 S. graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Karger |
| record_format | marc |
| series2 | Onkologie |
| spelling | Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie Phase-Eins-Studiengruppe Verfasser (DE-588)5290200-6 aut Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society E.-D. Kreuser ... Basel [u.a.] Karger 1998 VI, 70 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Onkologie 21, Suppl. 3 Kreuser, Ernst-Dietrich 1945- Sonstige (DE-588)17219699X oth |
| spellingShingle | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society |
| title | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society |
| title_auth | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society |
| title_exact_search | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society |
| title_full | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society E.-D. Kreuser ... |
| title_fullStr | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society E.-D. Kreuser ... |
| title_full_unstemmed | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society E.-D. Kreuser ... |
| title_short | Standard operating procedures and organization of German Phase I, II, and III Study Groups, New Drug Development Group (AWO), and Study Group of Pharmacology in Oncology and Hematology (APOH) of the Association for Medical Oncology (AIO) of the German Cancer Society |
| title_sort | standard operating procedures and organization of german phase i ii and iii study groups new drug development group awo and study group of pharmacology in oncology and hematology apoh of the association for medical oncology aio of the german cancer society |
| work_keys_str_mv | AT deutschekrebsgesellschaftarbeitsgemeinschaftfurinternistischeonkologiephaseeinsstudiengruppe standardoperatingproceduresandorganizationofgermanphaseiiiandiiistudygroupsnewdrugdevelopmentgroupawoandstudygroupofpharmacologyinoncologyandhematologyapohoftheassociationformedicaloncologyaioofthegermancancersociety AT kreuserernstdietrich standardoperatingproceduresandorganizationofgermanphaseiiiandiiistudygroupsnewdrugdevelopmentgroupawoandstudygroupofpharmacologyinoncologyandhematologyapohoftheassociationformedicaloncologyaioofthegermancancersociety |